Hepatic lipase affects both HDL and ApoB-containing lipoprotein levels in the mouse

Biochimica et Biophysica Acta - Lipids and Lipid Metabolism

Volumn 1392, Issue 2-3, 1998, Pages 276-290

  Braschi, Sylvie ^a   Couture, Nicole ^a   Gambarotta, Adriana ^a   Gauthier, Benoit R ^a   Coffill, Cynthia R ^a   Sparks, Daniel L ^a   Maeda, Nobuyo ^b   Schultz, Joshua R ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Apolipoproteins A I, A II, A IV, B100 48 and E; HL transgenic and deficient mice

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ENZYME ACTIVITY; GENE EXPRESSION; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEINS B; CHOLESTEROL, HDL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEPARIN; HUMANS; LIPASE; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHOLIPIDS; RNA, MESSENGER; SPECIES SPECIFICITY; TISSUE DISTRIBUTION;

MUS MUSCULUS;

EID: 0031804893     PISSN: 00052760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2760(98)00046-0     Document Type: Article

References (63)

1. Schoonderwoerd K., Hulsmann W.C., Jansen H. Stabilization of liver lipase in vitro by heparin or by binding to non-parenchymal liver cells. Biochim. Biophys. Acta. 665:1981;317-321.
2. Sanan D.A., Fan J., Bensadoun A., Taylor J.M. Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver. J. Lipid Res. 38:1997;1002-1013.
3. Shinomiya M., Sasaki N., Barnhart L., Shirai K., Jackson R.L. Effect of apolipoproteins on the hepatic lipase-catalyzed hydrolysis of human plasma high density lipoprotein 2-triacylglycerols. Biochim. Biophys. Acta. 713:1982;292-299.
4. Busch S.J., Barnhart R.L., Martin G.A., Fitzgerald M.C., Yates M.T., Mao S.J.T., Thomas C.E., Jackson R.L. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J. Biol. Chem. 269:1994;16376-16382.
5. Huff M.W., Sawyez C.G., Connelly P.W., Maguire G.F., Little J.A., Hegele R.A. β-VLDL in hepatic lipase deficiency induces apoE-mediated cholesterol ester accumulation in macrophages. Arterioscler. Thromb. 13:1993;1282-1290.
6. Shafi S., Brady S.E., Bensadoun A., Havel R.J. Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. J. Lipid Res. 35:1994;709-720.
7. Homanics G.E., de Silva H.V., Osada H., Zhang S., Wong H., Borenstajn J., Maeda N. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J. Biol. Chem. 270:1995;2974-2980.
8. Bamberger M., Lund-Katz S., Phillips M.C., Rothblat G.H. Mechanism of the hepatic lipase induced accumulation of high-density lipoprotein cholesterol by cells in culture. Biochemistry. 24:1985;3693-3701.
9. Bamberger M., Glick J.M., Rothblat G.H. Hepatic lipase stimulates the uptake of HDL cholesterol by hepatoma cells. J. Lipid Res. 24:1983;869-876.
10. Cohen J.C., Wang Z., Grundy S.M., Stoesz M., Guerra R. Variation in the hepatic lipase and apolipoprotein AI/CIII/AIV loci is the major cause of genetically determined variation in plasma high density lipoprotein cholesterol levels. J. Clin. Invest. 94:1994;2377-2384.
11. Guerra R., Wang J., Grundy S.M., Cohen J.C. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. USA. 94:1997;4532-4537.
12. Breckenridge W.C., Little J.A., Alauipovic P., Wang C.S., Kuksis A., Kakis G., Lindgren F., Gardiner G. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis. 45:1982;161-179.
13. Demant T., Carlson L.A., Holmquist L., Karpe F., Nilsson-Ehle P., Packard C.J., Shepard. Lipoprotein metabolism in hepatic lipase deficiency studies on the turnover of apolipoprotein B and on the effect on high density lipoprotein. J. Lipid Res. 29:1988;1603-1611.
14. Auwerx J.H., Babirak S.P., Hokanson J.E., Stahnke G., Will H., Deeb S.S., Brunzell J.D. Coexistence of abnormalities of hepatic lipase and lipoprotein lipase in a large family. Am. J. Hum. Genet. 46:1990;470-477.
15. Hegele R.A., Little J.A., Vezina C., Maguire G.F., Tu L., Wolever T.S., Jenkins D.J.A., Connelly P.W. Hepatic lipase deficiency: clinical, biochemical and molecular genetic characteristics. Arterioscler. Thromb. 13:1993;720-728.
16. Goldberg I.J., Le N.-A., Paterniti J.R. Jr., Ginsberg H.N., Lindgren F.T., Brown W.V. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase on the cynomolgus monkey. J. Clin. Invest. 70:1982;1184-1192.
17. Daggy B.P., Bensadoun A. Enrichment of apolipoprotein B-48 in the LDL density class following in vivo inhibition of hepatic lipase. Biochim. Biophys. Acta. 877:1986;252-261.
18. Sultan F., Lagrange D., Jansen H., Griglio S. Inhibition of hepatic lipase activity impairs chylomicron remnant-removal in rats. Biochim. Biophys. Acta. 1042:1990;150-152.
19. Kounnas M.Z., Chappell D.A., Wong H., Argraves W.S., Strickland D.K. The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans. J. Biol. Chem. 270:1995;9307-9312.
20. Nykjaer A., Nielsen M., Lookene A., Meyer N., Roigaard H., Etzerodt M., Beisiegel U., Olivecrona G., Gliemann J. A carboxyl-terminal fragment of lipoprotein lipase binds to the low density lipoprotein receptor-related protein and requires cell surface proteoglycans. J. Biol. Chem. 270:1995;9307-9312.
21. Krapp A., Ahle S., Kersting S., Hua Y., Kneser K., Nielsen M., Gliemann J., Beisiegel U. Hepatic lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor-related protein (LRP). J. Lipid Res. 37:1996;926-936.
22. Thuren T., Weisgraber K.H., Sisson P., Waite M. Role of apolipoprotein E in hepatic lipase catalyzed hydrolysis of phospholipid in high density lipoproteins. Biochemistry. 31:1992;2332-2338.
23. Sindelar P.J., Chojnacki T., Valtersson C. Role of apolipoprotein A-IV in hepatic lipase-catalyzed dolichol acylation and PL hydrolysis. Biochemistry. 36:1997;1807-1813.
24. Jahn C.E., Osborne J.C. Jr., Schaefer E.J., Brewer H.B. Jr. Activation of the enzyme activity of hepatic lipase by apolipoprotein A-II: characterization of a major component of high density lipoprotein as the activating plasma component in vitro. Eur. J. Biochem. 131:1983;25-29.
25. Mowri H.O., Patsch W., Smith L.C., Gotto A.M. Jr., Patsch J.R. Different reactivities of high density lipoprotein 2 subfractions with hepatic lipase. J. Lipid Res. 33:1992;1269-1279.
26. 3 for hepatic lipase. Arterioscler. Thromb. Vasc. Biol. 16:1996;755-762.
27. Zhong S., Goldberg I., Bruce C., Rubin E., Breslow J.L., Tall A.J. Human apoA-II inhibits the hydrolysis of HDL and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. Clin. Invest. 94:1994;2457-2467.
28. Weng W., Breslow J.L. Dramatically decreased HDL, increased remnant clearance, and insulin hypersensitivity in apoA-II knockout mice suggest a complex role for apoA-II. Proc. Natl. Acad. Sci. USA. 93:1996;14788-14794.
29. Homanics G.E., de Silva H.V., Osada H., Zhang S., Wong H., Borenstajn J., Maeda N. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J. Biol. Chem. 270:1995;2974-2980.
30. Fan J., Wang J., Bensadoun A., Lauer S.J., Dang Q., Mahley R.W., Taylor J.M. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. USA. 91:1994;8724-8728.
31. Southern E.M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:1975;503-517.
32. Chomczynski P., Sacchi N. Single step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 161:1987;156-159.
33. Chomczynski P. A reagent for the single-step simultaneous isolation for RNA, DNA and proteins from cell and tissue samples. BioTechniques. 15:1993;532-535.
34. Ehnholm C., Kuusi T. Preparation, characterization and measurement of hepatic lipase. Methods Enzymol. 129:1986;716-738.
35. Waite M., Thuren T.Y., Wilcox R.W., Sisson P.J., Kucera G.L. Purification and substrate specificity of rat hepatic lipase. Methods Enzymol. 197:1991;331-345.
36. Twu J.-S., Garfinkel A.S., Schotz M.C. Hepatic lipase: purification and characterization. Biochim. Biophys. Acta. 792:1984;330-337.
37. 3. J. Biol. Chem. 264:1989;6488-6494.
38. F.T. Lindgren, L.C. Jensen, F.T. Hatch, in: G.J. Nelson (Ed.), Blood Lipids and Lipoproteins, Wiley Interscience, New York, 1972, p. 181.
39. Selby S.L., Yao Z. Level of apolipoprotein B mRNA has an important effect of the synthesis and secretion of apolipoprotein B-containing lipoproteins. Studies on transfected hepatoma cell lines expressing recombinant human apolipoprotein B. Arterioscler. Thromb. Vasc. Biol. 15:1995;1900-1910.
40. Schultz J., Gong E., McCall M., Nichols A., Clift S., Rubin E.M. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice. J. Biol. Chem. 267:1992;21630-21636.
41. Cheng C.F., Bensadoun A., Bersot T., Hsu J.S.T., Melford K. Purification and characterization of human lipoprotein lipase and hepatic triglyceride lipase: reactivity with monoclonal antibodies to hepatic triglyceride lipase. J. Biol. Chem. 260:1985;10720-10727.
42. Milne R.W., Théolis Jr., Verdery R.B., Marcel Y.L. Characterization of monoclonal antibodies against human low density lipoprotein. Arteriosclerosis. 3:1983;23-30.
43. McFarlane A.S. Efficient trace labeling of proteins with iodine. Nature. 182:1958;53-54.
44. 131I-labeled plasma proteins. Phys. Med. Biol. 2:1957;36-53.
45. Reue K., Purcell-Huynh D.A., Leete T.H., Doolittle M.H., Durstenfeld A., Lusis A.J. Genetic variation in mouse apolipoprotein A-IV expression is determined pre- and post-transcriptionally. J. Lipid Res. 34:1993;893-903.
46. Kane J.P., Hardman D.A., Paulus H.E. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc. Natl. Acad. Sci. USA. 77:1980;2465-2469.
47. Cardin A.D., Witt K.R., Chao J., Margolius H.S., Donaldson V.H., Jackson R.L. Degradation of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins. J. Biol. Chem. 259:1984;8522-8528.
48. Dugi K.A., Vaisman B.L., Sakai N., Knapper C.L., Meyn S.M., Brewer B.H. Jr., Santamarina-Fojo S. Adenovirus-mediated expression of hepatic lipase in LCAT transgenic mice. J. Lipid Res. 38:1997;1822-1832.
49. Hayek T., Chajek-Shaul T., Walsh A., Agellon L.B., Moulin P., Tall A., Breslow J.L. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels. J. Clin. Invest. 90:1992;505-510.
50. Francone O.L., Gong E.L., Ng D.S., Fielding C.J., Rubin E.M. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein A-I and human apolipoprotein A-II on plasma lipoprotein cholesterol metabolism. J. Clin. Invest. 96:1995;1440-1448.
51. Mehlum A., Staels B., Duverger N., Tailleux A., Castro G., Fievet C.G., Fruchart J.C., Olivecrona G., Skretting G., et al. Tissue-specific expression of the human gene for lecithin:cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile. Eur. J. Biochem. 230:1995;567-575.
52. Hayek T., Masucci-Magoulas L., Jiang X., Walsh A., Rubin E., Breslow J.L., Tall A.R. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J. Clin. Invest. 96:1995;2071-2074.
53. Duverger N., Tremp G., Caillaud J.M., Emmanuel F., Castro G., Fruchart J.C., Steinmetz A., Denefle P. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science. 273:1996;966-968.
54. Choi S.Y., Komaromy M., Chen J., Fong L.G., Cooper A.D. Acceleration of uptake of LDL but not chylomicrons or chylomicron remnants by cells that secrete apoE and hepatic lipase. J. Lipid Res. 37:1996;197-208.
55. Zambon A., Austin M.A., Brown B.G., Hokanson J.E., Brunzell J.B. Effect of hepatic lipase on LDL in normal men and those with coronary. Arterioscler. Thromb. 13:1993;147-153.
56. Bengtsson G., Olivecrona T. The hepatic heparin releasable lipase binds to high density lipoproteins. FEBS Lett. 119:1980;290-292.
57. Knudsen P., et al. A compound heterozygote for hepatic lipase gene mutations Leu334→Phe and Thr383→Met: correlation between hepatic lipase activity and phenotypic expression. J. Lipid Res. 37:1996;825-834.
58. Attie A.D., Pittman R.C., Watanabe Y., Steinberg D. Low density lipoprotein receptor deficiency in cultured hepatocytes of the WHHL rabbit. Further evidence of two pathways for catabolism of exogenous proteins. J. Biol. Chem. 256:1981;9789-9792.
59. Choi S.Y., Komaromy M., Chen J., Fong L.G., Cooper A.D. Acceleration of uptake of LDL but not chylomicrons or chylomicron remnants by cells that secrete apoE and hepatic lipase. J. Lipid Res. 37:1996;197-208.
60. Kleinman Y., Krul E.S., Burnes M., Aronson W., Pfleger B., Schonfeld G. Lipolysis of LDL with phospholipase A2 alters the expression of selected apoB-100 epitopes and the interaction of LDL with cells. J. Lipid Res. 29:1988;729-743.
61. Singh T.K.A., Liu H., Bradley R., Scraba D.G., Ryan R.O. The effect of phospholipase C and apolipophorin III on the structure and stability of lipophorin subspecies. J. Lipid Res. 35:1994;1561-1569.
62. Singh T.K.A., Scraba D.G., Ryan R.O. Conversion of human low density lipoprotein into a very low density lipoprotein-like particle in vitro. J. Biol. Chem. 267:1992;9275-9280.
63. de Silva H.V., Mas-Oliva J., Taylor J.M., Mahley R.W. Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse. J. Lipid Res. 35:1994;1297-1310.